Back to Treatments

Treatment

Intravenous Iron Dextran (High Molecular Weight)

1
Conditions
50
Trials
10K
Participants
60%
Average Safety

Condition Evidence

Iron Deficiency Anemia

50 trials · 10K participants

87% effectiveness · 60% safety
Intravenous Iron Dextran (High Molecular Weight) | DFDA